InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+7.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Kurtz Ronald M MD, Autre. Officer active across 1 company, notably RxSight, Inc.. Cumulatively, 9 filings have been recorded. Split: 2 buys · 4 sells. Total volume traded: €8.4m. Activity tracked since 3 August 2021. The latest transaction was filed on 9 August 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
7,650 shares@ US$15.08181.2% of flowCommon StockSEC:0000950170-24-094918:0
13,500 shares@ US$15.08182.0% of flowCommon StockSEC:0000950170-24-083334:0
40,000 shares@ US$60.146824.4% of flowCommon StockSEC:0000950170-24-053667:0
31,250 shares@ US$43.5013.5% of flowCommon StockSEC:0000950170-24-003332:0
22,500 shares@ US$41.08889.1% of flowCommon StockSEC:0001209191-23-060012:0
20,000 shares@ US$40.00828.0% of flowCommon StockSEC:0001209191-23-059039:0
40,000 shares@ US$12.505.1% of flowCommon StockSEC:0001209191-23-008846:0
125,000 shares@ US$16.000.72% mcap50.0% of flowCommon StockSEC:0000899243-21-031814:0
Canonical exit: 1 Nov 2021 (T+90)
125,000 shares@ US$16.0018.3% of flowCommon StockSEC:0000899243-21-031814
Canonical exit: 1 Nov 2021 (T+90)
9 of 9 declarations
About Kurtz Ronald M MD
Ronald M. Kurtz is associated with RxSight, Inc. His role is specified as 'See Remarks', indicating potential involvement in various aspects of the company. Ronald brings his expertise in the medical field, contributing to the company's strategy and innovation. His experience is valuable in guiding RxSight in a constantly evolving environment.
